GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers
Source: Pixabay.com

GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers

According to OncLive, Oncolytics Biotech and Roche are pairing up to run a new German Phase ½ clinical trial. The GOBLET trial will evaluate pelareorep in conjunction with atezolizumab (Tecentriq)…

Continue Reading GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers

Desperate Housewives Actress Marcia Cross Says She Feels “Liberated” After Sharing Her Battle with Anal Cancer

Actress Marcia Cross, best known for her role as Bree Van de Kamp on Desperate Housewives, has shared that she is now healthy after battling anal cancer in a series…

Continue Reading Desperate Housewives Actress Marcia Cross Says She Feels “Liberated” After Sharing Her Battle with Anal Cancer
Lower Income Patients With Anal Cancer Are More Likely to Die Compared to Wealthier Patients
Source: Pixabay

Lower Income Patients With Anal Cancer Are More Likely to Die Compared to Wealthier Patients

According to a story from cancercompass.com, a recent study has demonstrated that income level is a significant factor in determining survival for patients with anal cancer. In general, the study…

Continue Reading Lower Income Patients With Anal Cancer Are More Likely to Die Compared to Wealthier Patients